Clinical Trials Browser

Phase 4 × Completed × Dasatinib × Clear all

NCT04925141 2021-06-14

A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

Phase 4 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT01660906 2016-11-22

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

Phase 4 Completed

39 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase